## Acute Pancreatitis: Management Principles and Prognostic Markers ### Correct Answer Analysis **Key Point:** ERCP with sphincterotomy is NOT indicated in all cases of acute pancreatitis. It is reserved for specific subsets: acute biliary pancreatitis with **persistent cholangitis** or **biliary obstruction** (elevated bilirubin, dilated CBD on imaging). Routine ERCP in uncomplicated acute pancreatitis increases morbidity without benefit. ### Why the Other Options Are Correct | Feature | Evidence | |---------|----------| | **Procalcitonin at 48 hrs** | Elevated levels (>0.5 ng/mL) predict organ failure, secondary infection, and mortality; more specific than CRP for bacterial infection [cite:Harrison 21e Ch 346] | | **SIRS Criteria** | ≥2 SIRS criteria on admission are associated with increased risk of organ failure and prolonged hospital stay; part of prognostic scoring | | **CRP elevation beyond day 3** | Persistent elevation suggests secondary pancreatic infection (walled-off necrosis, abscess); normal CRP decline argues against infection | ### Clinical Pearl **High-Yield:** ERCP indications in acute pancreatitis: - Acute biliary pancreatitis + **cholangitis** (fever, jaundice, elevated transaminases) → ERCP within 24 hrs - Acute biliary pancreatitis + **persistent biliary obstruction** (bilirubin >4 mg/dL, dilated CBD) → ERCP within 24–48 hrs - Idiopathic or alcohol-induced pancreatitis → ERCP NOT indicated ### Prognostic Markers in Acute Pancreatitis | Marker | Timing | Significance | |--------|--------|-------------| | **Procalcitonin** | 48 hrs | >0.5 ng/mL predicts organ failure, infection | | **CRP** | Day 3–5 | Peak at 72 hrs; persistent elevation suggests necrosis/infection | | **SIRS score** | Admission | ≥2 criteria = worse prognosis | | **APACHE II, SOFA** | Admission, day 1 | Quantify organ dysfunction | | **Lactate** | Admission | Elevated = tissue hypoperfusion, poor prognosis | [cite:Harrison 21e Ch 346]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.